Merck's Oral PCSK9 Cholesterol Pill, Lilly's…

Katerina Roznik

Jul 17

Lipfendra becomes the first oral drug to match injectable cholesterol lowering, Lilly enters psychedelics with an $2.8B AtaiBeckley acquisition, and the FDA dismantles Makary's methods (7/10-16, 2026)

2 Comments

Your weekly summaries / analysis are terrific. Thanks.

Katerina Roznik

Thank you, Arie! Appreciate it :)

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts